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It is an exciting time for food allergy. Not only is diagnosis being revolutionized by using a molecular approach [1] , but strategies of new treatment approaches are being evaluated in many studies. Among them, studies on oral tolerance are bringing a new perspective to the management of patients with food allergies [2] .
Immunotherapy is part of the routine management of respiratory allergies and has been utilized for over a century [3] . One area of allergy that has not yet seen immunotherapy become part of standard practice is food allergy. Although the first article of successful immunotherapy for food allergy was published in 1923, when it was alluded to as 'an attempt to increase the resistance of the patient to the offending substance' [4] , no new reports aside from single case reports emerged until the 1990s when subcutaneous immunotherapy (SCIT) for peanut allergy was reported [5] . In this double-blind, placebo-controlled trial of rush immunotherapy in peanut allergic patients, significant improvements in threshold doses at double-blind, placebo-controlled food challenge was seen in three patients following treatment. Unfortunately, the study was prematurely terminated due to a fatal adverse reaction. As a handful of other attempts at SCIT for food allergy were also fraught with unacceptably high rates of systemic allergic reactions [6] , the very notion of immunotherapy as a potential treatment strategy for food allergies was all but disregarded.
In the past decade, there has been renewed interest in immunotherapy as a treatment for food allergy. With new hypotheses of oral exposures to allergens as having a tolerogenic effect, oral administration of immunotherapy has garnered significant attention. An increasing number of studies have been published in Europe and the United States demonstrating the effects of oral and sublingual immunotherapy in modulating the immune response to the major allergens, including milk, egg, and peanut. Several well designed studies, including randomization and placebo controls, have been reporting the effectiveness of immunotherapy for increasing tolerance levels to a variety of foods, suggesting that immunotherapy is a viable option for managing food allergies [7] [8] [9] . In this issue, the studies on egg [10] and milk [11] immunotherapy are reviewed. This has led to a paradigm shift in the field of food allergy, and strict avoidance may not be the only management strategy [12] . Partial avoidance, identified as a form of oral immunotherapy, could realize 'a vastly altered approach to food allergy management', allowing 'a substantial improvement to the quality of life of milk-allergic individuals' [13] . The brilliant review published here overviews the recent studies on the possibility of introducing baked milk and egg into the diet of otherwise allergic patients [14] .
Results from these published studies are starting to answer several questions underlying the process and mechanisms of immunotherapy. Some questions include clinical outcomes achieved by immunotherapy (desensitization versus tolerance), optimal routes of administration (oral, sublingual), allergen type (whole protein, heat denatured protein), as well as optimal protocol (dosing, duration of treatment).
Although results thus far seem promising for achieving desensitization (and tolerance at least in a subset of individuals), immunotherapy is not without risks. Severe allergic reactions requiring treatment with epinephrine have been reported [9] , as well as some cases of eosinophilic esophagitis [15] . Even in the case of immunotherapy with heatdenatured allergens, although a significant majority of milk and egg allergic individuals can tolerate the heat denatured forms, there is no quick, easy test to determine whether a child is or is not tolerant other than oral food challenge, which must be performed with caution in an observed setting as severe allergic reactions to extensively heated milk and egg have been reported [16, 17] .
At this juncture, we do not yet have enough information to decide whether the risks and benefits tip in favor of intervention or continued avoidance [18] . It is important to realize that these decisions will likely depend on a number of factors, such as age of the child, severity of past reactions, and food allergen in question. For foods such as milk and egg in which the most common natural history is spontaneous outgrowth in childhood, the risks of therapeutic intervention might not outweigh the benefits, particularly in young children [19] . On the contrary, for persistent allergies such as peanut, intervening may be the only option for the majority of patients.
For these reasons, the current standard of care continues to entail strict avoidance of the food allergen(s) and immediate availability of emergency medications in case of accidental allergic reactions, as recommended by the recently published food allergy guidelines [20] [21] [22] . These guidelines were developed based on systematic reviews and metaanalyses of the existing literature as well as expert opinions from recognized leaders in food allergy. The field of food allergy has the fortune of being one of the few fields of medicine with GRADEd (grading of recommendations assessment, development and evaluation) guidelines. It is when uncertainty is high that the clinician needs a guide to orient the patient-by-patient, day-to-day practice of evidencebased medicine. The publication of these guidelines provides an important opportunity for us to review our knowledge base and standardize our practices to ensure that we are providing optimal care for our patients [23] .
In addition to providing a concise summary of current evidence-based recommendations, the guidelines identify key gaps in knowledge and highlight areas of controversy in patient management that provide a framework for us to consider future research endeavors. Although great strides have already been made in the understanding of the scope of the problem of food allergy and of the mechanisms underlying the clinical symptoms, our practice will continue to evolve as there is still much more to be learned and discovered.
